ChemicalBook > Product Catalog >API >Antibiotics >Cephalosporins Drugs >Cefixime

Cefixime

Cefixime Structure
CAS No.
79350-37-1
Chemical Name:
Cefixime
Synonyms
CEFIXIME TRIHYDRATE;Cefixim;Cefspan;Suprax;Cefixime USP;CEFIXIME MICRONIZED;CFIX;fk027;Oroken;Saprax
CBNumber:
CB4210362
Molecular Formula:
C16H15N5O7S2
Molecular Weight:
453.45
MOL File:
79350-37-1.mol
MSDS File:
SDS
Modify Date:
2024/5/27 15:57:40

Cefixime Properties

Melting point 218-225°C
Density 1.85±0.1 g/cm3(Predicted)
storage temp. Keep in dark place,Inert atmosphere,2-8°C
solubility Slightly soluble in water, soluble in methanol, sparingly soluble in anhydrous ethanol, practically insoluble in ethyl acetate.
pka pKa 2.10 (Uncertain)
form Solid
color Off-White to Pale Yellow
Water Solubility 55.11 mg/L
BCS Class 4
Stability Hygroscopic
CAS DataBase Reference 79350-37-1(CAS DataBase Reference)

SAFETY

Risk and Safety Statements

Symbol(GHS) 
GHS07
Signal word  Warning
Hazard statements  H302-H315-H319-H335
Precautionary statements  P261-P305+P351+P338
Hazard Codes  Xn
Risk Statements  42/43
Safety Statements  22-36/37-45
WGK Germany  3
10-23
HS Code  38210000
Toxicity LD50 oral in rat: > 10gm/kg

Cefixime price More Price(1)

Manufacturer Product number Product description CAS number Packaging Price Updated Buy
Sigma-Aldrich(India) CDS021590 Cefixime 79350-37-1 100MG ₹10760.05 2022-06-14 Buy
Product number Packaging Price Buy
CDS021590 100MG ₹10760.05 Buy

Cefixime Chemical Properties,Uses,Production

Description

Cefixime is the first orally active third-generation cephalosponn with a true broad spectrum of activity. It is reportedly more effective against Gram-negative bacteria than conventional oral cephems such as cephalexin and cefaclor.

Chemical Properties

Cefixime is an oral third generation cephalosporin antibiotic. It was sold under the trade name Suprax in the United States until 2003. The oral suspension form of “Suprax” was re-launched. Cefixime is prescribed for bacterial infections of the chest, ears, urinary tract, and throat (tonsilitis and pharyngitis), and for uncomplicated gonorrhea, upper and lower respiratory tract infections, acute otitis media, and gonococcal urethritis.

Definition

ChEBI: A third-generation cephalosporin antibiotic bearing vinyl and (2Z)-2-(2-amino-1,3-thiazol-4-yl)-2-[(carboxymethoxy)imino]acetamido groups at positions 3 and 7, respectively, of the cephem skeleton. It is used in the treatment of gonorrhoea tonsilitis, pharyngitis, bronchitis, and urinary tract infections.

Antimicrobial activity

It is active against N. gonorrhoeae, M. catarrhalis, H. influenzae and a wide range of enterobacteria, including most strains of Citrobacter, Enterobacter and Serratia spp. Its antistaphylococcal activity is poor. It is not active against Acinetobacter spp., Ps. aeruginosa or B. fragilis. It is resistant to hydrolysis by common β-lactamases.

Health Hazard

Exposures to cefi xime may cause side effects that include, but are not limited to, stomach and abdominal pain, diarrhea, vomiting, mild skin rash, headache, fever, urticaria, pruritis, eosinophilia, leucopenia, anaphylaxis, superinfection, hemolytic anemia, dyspepsia, and fl atulence. Also, cefi xime may cause transient elevation of SGOT, SGPT, alkaline phosphatase, BUN, and creatinine. Reports have indicated that cefi xime is mainly excreted unchanged in the bile and urine

Pharmacokinetics

Oral absorption: c. 50%
Cmax 400 mg oral: 4–5.5 mg/L after 4 h
Plasma half-life: 3-ndash;4 h
Volume of distribution: 0.1 L/kg
Plasma protein binding: 60-ndash;70%
Absorption and distribution
Oral absorption is slow and incomplete, but is unaffected by aluminum magnesium hydroxide. Penetration into cantharides blister fluid was very slow but exceeded the plasma level. CSF concentrations are poor even in the presence of meningeal inflammation, reaching an average of around 0.22 mg/L in children with meningitis.
Metabolism and excretion
It is not metabolized and is excreted unchanged in urine (mainly by glomerular filtration) and in bile, in which concentrations exceeding 100 mg/L have been found. Less than 20% of an oral dose is recovered from the urine over 24 h, falling to less than 5% in patients with severe renal impairment, with a corresponding increase in plasma concentration. It is not removed by peritoneal or hemodialysis.

Clinical Use

Cefixime has been used successfully in uncomplicated cystitis, upper and lower respiratory tract infections and various other infections. Its failure to provide adequate cover for staphylococci should be noted.

Side effects

It is well tolerated, but diarrhea is fairly common and pseudomembranous colitis has been reported. Other side effects common to cephalosporins are occasionally seen.

Precautions

Users of cefi xime should be careful in health conditions such as neonates, pregnancy, lactation, and renal failure. Users should follow suitable and appropriate health care measures to control superinfection (if it happens during therapy). It is contraindicated in patients with a known allergy to penicillin or any other ingredients of Taximax. Taxim-O is contraindicated in patients with a known allergy to the cephalosporin group of antibiotics.

Global( 543)Suppliers
Supplier Tel Country ProdList Advantage Inquiry
Hetero Drugs Limited +91-4023704923 +91-4023704923 Telangana, India 296 58 Inquiry
Ralington Pharma +91-7948911722 +91-9687771722 Gujarat, India 1350 58 Inquiry
Concept Pharmaceuticals Ltd +91-2242418888 +91-2242418888 Maharashtra, India 19 58 Inquiry
Unimark Remedies Ltd +91-2267304120 +91-2267304120 Maharashtra, India 48 58 Inquiry
Covalent Laboratories Private Limited (Virchow Group) +91-4049483333 +91-9866077161 Telangana, India 9 58 Inquiry
Shree Nath Life Sciences Pvt., Ltd. 91-11-23864528 Delhi, India 15 58 Inquiry
Aligns International 91-22-22634745 Maharashtra, India 137 58 Inquiry
Shivam Pharma Chemicals 91-22-26403900 Maharashtra, India 656 58 Inquiry
Akhil Healthcare Pvt., Ltd. 91-265-3018080 Gujarat, India 71 58 Inquiry
OCEAN TRADING CORPORATION +91(22) 24921669 New Delhi, India 6211 58 Inquiry

Related articles

YTTERBIUM(III) IONOPHORE I )(carboxymethoxy)imino)acetylamino)-3-ethenyl-8-oxo-,(6r-(6-alpha,7-beta(z))) cl284635 fk027 fr17027 8-[[2-(2-amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-4-ethenyl-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid (6R,7R)-7-[2-(2-AMINO-4-THIAZOLYL)GLOXYLAMIDO]-8-OXO-3-VINYL-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID, 72-(Z)-[O-(CARBOXYMETHYL)OXIME]TRIHYDRATE CEFIXME TRIHYDRATE CEFIXIME CEFIXIME CEPHALOSPORINS Cefixime (comp) (6R,7R)-7-[[(2Z)-2-(2-Amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid Cefixoral Cephoral Unixime 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-(2-amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)- (9CI) Oroken Ceftmral CFIX Saprax Supracef CEFIXIME(7-[[(2-AMINO-4-THIAZOLGL)(CARBOXYMETHOXG)IMINO]ACETYL]AMINO-3-VINYL-8-OXO-5-THIA-1-AZABICYCLO[4,2,0]OCT-2-ENE-2-CARBOXYLICACIDTRIHYDRATE) (6R,6β)-7α-[[(2-Amino-4-thiazolyl)[(Z)-(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-[[(Z)-(2-Amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid Antibiotic FK-027 Cefixime (500 mg) Cexime (500 mg) [6R-[6α,7β(Z)]]-7-[[(2-Amino-4-thiazolyl)[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-[(2E)-2-(2-aMino-1,3-thiazol-4-yl)-2-[(carboxyMethoxy)iMino]acetaMido]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid (6R,7R)-7-({(2Z)-2-(2-AMINO-1,3-THIAZOL-4-YL)-2-[(CARBOXYMETHOXY)IMINO]ACETYL}AMINO)-8-OXO-3-VINYL-5-THIA-1-AZABICYCLO[4.2.0]OCT-2-ENE-2-CARBOXYLIC ACID AcetazolaMide IMpurity C Cefixime Trihydrate (Micronized) 8-[[2-(2-Amino-1,3-thiazol-4-yl)-2-(carboxymethoxyimino)acetyl]amino]-4-ethenyl-7-oxo-2-thia-6-azabicyclo[4.2.0]oct-4-ene-5-carboxylic acid trihydrate (6R,7R)-7-((Z)-2-(2-Aminothiazol-4-yl)-2-((carboxymethoxy)imino)acetamido)-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylicacid 7-[[2-(2-amino-4-thiazolyl)-2-(carboxymethoxyimino)-1-oxoethyl]amino]-3-ethenyl-8-oxo-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid trihydrate Cefixime CRS Cefiximum Cefixime Δ3 isomer impurity 5-Thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic acid, 7-[[(2Z)-2-(2-amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetyl]amino]-3-ethenyl-8-oxo-, (6R,7R)- Cefixime USP/EP/BP Cefixime Cefspan Oroken Cefixime EP Impurity D (cefixime (E)-isomer) Cefixime 13C 15N2Q: What is Cefixime 13C 15N2 Q: What is the CAS Number of Cefixime 13C 15N2 Q: What is the storage condition of Cefixime 13C 15N2 Q: What are the applications of Cefixime 13C 15N2 CefiximeQ: What is Cefixime Q: What is the CAS Number of Cefixime CEFIXIME TRIHYDRATE Suprax CEFIXIME MICRONIZED Cefspan Cefixim Cefixime USP Cefixime Δ3 isomer impurity Cefixime double chain Impurity (6R,7R)-7-[(Z)-2-(2-Amino-4-thiazolyl)-2-[(carboxymethoxy)imino]acetamido]-8-oxo-3-vinyl-5-thia-1-azabicyclo[4.2.0]oct-2-ene-2-carboxylic Acid 79350-37-1 C16H15N5S2O7 C16H15N5O7S2 C16H21N5O10S2 Pharmaceutical intermediates